Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer.


Journal Article

Full Text

Duke Authors

Cited Authors

  • Zighelboim, I; Wright, JD; Powell, MA; Case, AS; Eisenhauer, EL; Cohn, DE; Valea, FA; Secord, AA; Lippmann, LT; Rader, JS

Published Date

  • May 20, 2010

Published In

Volume / Issue

  • 28 / 15_suppl

Start / End Page

  • TPS252 - TPS252

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2010.28.15_suppl.tps252


  • en